GCH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.167200E-01
Normal-vs-Stage2
5.312800E-01
Normal-vs-Stage3
6.830400E-01
Normal-vs-Stage4
6.915600E-01
Stage1-vs-Stage2
2.740000E-01
Stage1-vs-Stage3
3.633000E-01
Stage1-vs-Stage4
3.088600E-01
Stage2-vs-Stage3
9.544000E-01
Stage2-vs-Stage4
8.439200E-01
Stage3-vs-Stage4
8.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.651600E-01
Normal-vs-AfricanAmerican
4.723000E-01
Normal-vs-Asian
9.854200E-02
Caucasian-vs-AfricanAmerican
1.131000E-01
Caucasian-vs-Asian
1.380290E-03
AfricanAmerican-vs-Asian
5.035200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.487200E-01
Normal-vs-Female
9.705200E-01
Male-vs-Female
2.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.851800E-01
Normal-vs-Age(41-60Yrs)
8.275200E-01
Normal-vs-Age(61-80Yrs)
9.414000E-01
Normal-vs-Age(81-100Yrs)
1.842990E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.291000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.933190E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.177600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.343200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.662500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.304000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.000400E-01
Normal-vs-Daily Drinker
9.785800E-01
Normal-vs-Weekly Drinker
2.625400E-01
Normal-vs-Occasional Drinker
7.939800E-01
Normal-vs-Social Drinker
8.379000E-01
Non Drinker-vs-Daily Drinker
1.673450E-01
Non Drinker-vs-Weekly Drinker
9.571200E-01
Non Drinker-vs-Occasional Drinker
2.631600E-01
Non Drinker-vs-Social Drinker
1.528840E-01
Daily Drinker-vs-Weekly Drinker
2.063200E-01
Daily Drinker-vs-Occasional Drinker
5.194200E-01
Daily Drinker-vs-Social Drinker
6.490800E-01
Weekly Drinker-vs-Occasional Drinker
2.707200E-01
Weekly Drinker-vs-Social Drinker
1.708840E-01
Occasional Drinker-vs-Social Drinker
6.949600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.074800E-01
Normal-vs-Grade 2
6.258600E-01
Normal-vs-Grade 3
5.795400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.701900E-02
Grade 1-vs-Grade 3
2.995900E-02
Grade 1-vs-Grade 4
5.074800E-01
Grade 2-vs-Grade 3
3.692800E-01
Grade 2-vs-Grade 4
6.258600E-01
Grade 3-vs-Grade 4
5.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.912000E-01
Normal-vs-NonDiabetic
9.231000E-01
Diabetic-vs-NonDiabetic
7.975600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.301700E-02
Normal-vs-NoPancreatitis
8.897800E-01
Pancreatitis-vs-NoPancreatitis
6.245300E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.017000E-01
Normal-vs-N1
5.460800E-01
N0-vs-N1
4.129600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.922600E-01
Normal-vs-TP53-NonMutant
7.053700E-02
TP53-Mutant-vs-TP53-NonMutant
8.798800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
